February 25, 2020
Gamida Cell Reports Full Year 2019 Financial Results and Provides Company Update
– Completed patient enrollment in Phase 3 clinical study of omidubicel; Topline data expected in the second quarter of 2020…
Pharmaceuticals, Biotechnology and Life Sciences
– Completed patient enrollment in Phase 3 clinical study of omidubicel; Topline data expected in the second quarter of 2020…
Funding to support the Aria CV Pulmonary Hypertension System Feasibility Study Financing led by Xeraya Capital ST. PAUL, Minn.–(BUSINESS WIRE)–Aria…
Bicycle will receive a $30 million upfront payment; upfront payment and potential discovery, development, regulatory and commercial milestones could total…
DUBLIN–(BUSINESS WIRE)–The “Cartilage Repair/ Cartilage Regeneration – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering. Cartilage…
– Industry veteran, Max Colao, appointed Chief Commercial Officer – – Recruited four seasoned executives with expertise across critical commercial…
CARB-X Award Worth up to $12.17M USD to Develop Peptilogics’ Lead Compound in Prosthetic Joint Infection and Accelerate Development of…
Company’s Flagship Product, Clinical Studio, to be Consolidated under TrialKit Brand RENO, Nev.–(BUSINESS WIRE)–#clinicalresearch–Crucial Data Solutions, Inc. (CDS), a leading…
To develop and launch a kit dedicated to sample preparation for single-cell RNA-sequencing PARIS–(BUSINESS WIRE)–Scipio bioscience, a Paris-based biotechnology company,…
COPENHAGEN, Denmark–(BUSINESS WIRE)–Liva Healthcare continues its impressive growth trajectory with the appointment of a Chief Commercial Officer (CCO) and 13…
17th patient dosed in the ongoing phase 2/3 AAVance study PARIS–(BUSINESS WIRE)–Regulatory News: Lysogene (Paris:LYS) (FR0013233475 – LYS), a pioneering…